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Recent RNA-sequencing studies have shown remarkable complexity in the mammalian transcriptome. The ultimate
impact of this complexity on the predicted proteomic output is less well defined. We have undertaken strand-specific RNA
sequencing of multiple cellular RNA fractions (>20 Gb) to uncover the transcriptional complexity of human embryonic
stem cells (hESCs). We have shown that human embryonic stem (ES) cells display a high degree of transcriptional diversity,
with more than half of active genes generating RNAs that differ from conventional gene models. We found evidence that
more than 1000 genes express long 59 and/or extended 39UTRs, which was confirmed by ‘‘virtual Northern’’ analysis.
Exhaustive sequencing of the membrane-polysome and cytosolic/untranslated fractions of hESCs was used to identify
RNAs encoding peptides destined for secretion and the extracellular space and to demonstrate preferential selection of
transcription complexity for translation in vitro. The impact of this newly defined complexity on known gene-centric
network models such as the Plurinet and the cell surface signaling machinery in human ES cells revealed a significant
expansion of known transcript isoforms at play, many predicting possible alternative functions based on sequence al-
terations within key functional domains.
[Supplemental material is available for this article.]
Human embryonic stem cells (hESCs) are an excellent model sys-
tem for studying both pluripotency and directed differentiation.
They also have the potential to provide an unlimited source of cells
for therapeutic applications. The genes that maintain the un-
differentiated stem cell state have been identified through a variety
of array-based mRNA studies, proteomic profiling, functional ge-
nomic knockdown screening, and transcription factor ChIP ap-
proaches (Brandenberger et al. 2004a,b; Richards et al. 2004; Assou
et al. 2007; Muller et al. 2008). These approaches have highlighted
the importance of the ‘‘Plurinet,’’ a regulatory network of 299
protein-coding genes believed to interact and maintain the embry-
onic stem cell (ESC) state and the importance of the extracellular
space in maintaining the stem-like state.
One challenge to studying pluripotency is that gene-centric
models such as the Plurinet do not adequately reflect the true mo-
lecular complexity underlying these networks. This limitation arises
from the ‘‘gene-centric’’ approach used to create these models,
where each actively expressed gene is represented as a single node
in the network that expresses a single transcript, which, in turn,
encodes a single canonical peptide (Brandenberger et al. 2004a,b;
Richards et al. 2004; Assou et al. 2007; Muller et al. 2008). Such
models neglect the true complexity of transcriptional output in
higher eukaryotes that is created by alternative splicing, multiple
promoter usage, 39-UTR switching, expression of non-coding RNAs,
and RNA-mediated control via the likes of miRNAs (Carninci et al.
2005; The ENCODE Project Consortium 2007; Chekulaeva and
Filipowicz 2009).
Until recently, defining transcriptional complexity in single
biological states has proven challenging. Massive-scale shotgun next-
generation sequencing of cDNAs (also known as RNA-seq) has been
shown to provide the means for simultaneous monitoring gene
activity and canonical and variant mRNA expression arising from
alternate splicing, and the means to detect alternative promoter or
39-UTR usage (Cloonan et al. 2008; Mortazavi et al. 2008; Wang
et al. 2008; Wilhelm et al. 2008) in any biological state. Indeed,
both mouse and human stem cells have recently been analyzed in
this fashion (Cloonan et al. 2008; Wu et al. 2010). One major
limitation arising in these studies has been the inability to confi-
dently assign biological activity to the RNA detected by RNA-seq.
While an mRNA may be actively transcribed, it may not be trans-
lated due to transcriptional pausing, illegitimate transcription,
poor splicing, and nonsense-mediated decay (Chang et al. 2007;
Maier et al. 2009). Other challenges in assigning biological activity
to RNA detected by RNA-seq include the difficulty in distinguish-
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ing overlapping transcripts from a single locus and in accurately
delineating novel expression when this expression is closely as-
sociated with known genes.
In this study, we report on the overall transcriptional output
of human embryonic stem cells by deep sequencing of cytoplas-
mic RNA. We perform a systematic review of novel expression and
show that sequence-based ‘‘virtual Northern blot’’ analysis im-
proves variant detection and reveals a dramatic expansion of the
hESC exome through long 39-UTR usage. To help illuminate the
biological activity of expressed mRNA, we have examined which
actively transcribed mRNAs are also actively translated in hESCs.
We describe the use of free and membrane polysome-associated
RNA fractions to perform sequence-based translation state anal-
ysis and to identify which actively translated RNA transcripts
encode peptides destined for the hESC extracellular space. We
have identified hESC-specific non-canonical splice junctions and
39-UTR extension events by comparing RNA-seq data from hES
cells with that of three human tissues, namely, brain, heart, and
liver. Finally, we have used this information to reannotate the
classical models of key pluripotency regulatory networks so that
they are now transcript-specific, uncovering a substantial in-
crease in the number and complexity of components active in the
hESC Plurinet.
Results
Sequencing the human ESC transcriptome
A thorough survey of the human ESC transcriptome (HES-2 cell
line) was generated using strand-specific shotgun sequencing (Tuch
et al. 2010) of the following ribosomal RNA-depleted RNA pop-
ulations: (1) cytoplasmic, poly-adenylated RNA (known hereafter
as the ‘‘mRNA’’ fraction); (2) cytoplasmic polyadenylated RNA size-
fractionated into five subpopulations (<0.5 kb, 0.5–2 kb, 2–3.5 kb,
3.5–6.5 kb, >6.5 kb); and (3) membrane-bound (‘‘MPR’’ fraction)
and free/cytosolic (‘‘CPR’’ fraction) polysome-associated RNAs
isolated using cyclohexamide treatment and sucrose gradient ul-
tracentrifugation (Supplemental Figs. S1, S2; Diehn et al. 2000, 2006;
Stitziel et al. 2004). In total, 674 million mappable tags were gen-
erated across all libraries (Table 1) using a combination of single
fragment or paired-end reads at lengths ranging from 25 to 75 bp.
Tags were recursively mapped to both the human genome (GRCh37)
and a curated library of known exon–exon junctions using BioScope
(Life Technologies). All mapped data can be viewed as IGV-accessible
BAM and wig/tdf files at http://grimmond.imb.uq.edu.au/hES_
transcriptome.
Quantifying human ESC locus activity
As a first step, the overall locus activity for hESCs was calculated.
The majority (61%–91%) of unique reads mapped to exonic se-
quences of known or predicted genes (Table 1), which was consis-
tent with other studies (Cloonan et al. 2008; Mortazavi et al. 2008).
The directionality of the library preparative method was confirmed
by a >10,000-fold enrichment of tags matching to exon junctions
in a sense versus antisense orientation (Supplemental Fig. S3). A
total of 14,081 unique genes were found to be active at a level of 1
mRNA transcript per cell or greater in the mRNA fraction (based on
the estimate that one read per kilobase per million tags, or RPKM,
equates to 1 transcript per cell) (Mortazavi et al. 2008).
To confirm that this active gene profile was accurate, the rel-
ative expression was compared with previously published strand-
non-specific RNA sequencing of hESCs (Pearson correlation = 0.94)
(Supplemental Fig. S4B; Wu et al. 2010). We also used these data to
investigate expression of genes (n = 2990 genes) previously de-
scribed as being inactive in hESCs based on microarray and mas-
sively parallel signature sequencing (MPSS) data (Boyer et al. 2005;
Guenther et al. 2007). Despite the stringent criteria by which the
inactive gene set was originally defined, we found that ;20% of
the genes (n = 535 genes) were detected by RNA-seq (RPKM $ 1).
Furthermore, 115 of these genes were expressed at high levels
(RPKM > 5) (Table 2; Supplemental Table S1). To increase confi-
dence in expression of these genes, RNA-seq data for these genes
were aligned with human ES cell chromatin immunoprecipitation
sequencing (ChIP-seq) data for three histone H3 lysine trimethyla-
tion modifications indicative of transcriptional initiation (H3K4me3),
elongation (H3K36me3), and repression (H3K27me3) (Ku et al. 2008).
In the majority of such cases (77/115) expression was supported by
the presence H3K4me3 and H3K36me3 as well as the absence of
H3K27me3.
Alternative splicing in hESCs
Alternative splicing is a powerful method for expanding the tran-
scriptomic and proteomic output of mammalian cells (Forrest et al.
2006). Alternative splicing events are readily identified in RNA-seq
experiments using sequence tags that span exon–exon junctions.
A total of 121,728 unique high-confidence exon junctions (sup-
ported by >8 tags) were identified within hESCs. Of these alter-
natively splicing events, 5698 were for non-canonical exon com-
binations, with 65% of these events independently supported by
both fragment and paired-end sequencing (Supplemental Table
S2A,B). In 250 cases, the non-canonical junction was expressed at
least fivefold higher than the canonical (Supplemental Table S2).






RNA (C/S RNA) Size libraries
Individual libraries 9 4 4 5
All tags (not quality filtered) 586,724,412 333,341,410 313,569,864 186,630,528
Mapped tags (all) 320,803,293 152,941,951 164,457,787 36,452,461
Filtered tags (rRNA, tRNA) 4,563,347 17,038,518 21,109,746 531,032
Uniquely mapped tags 208,308,063 76,875,611 90,275,927 7,931,376
Sequence (Gb) 9.728 3.945 4.422 0.32
Map across junctions 16,270,746 3,782,646 3,700,150 212,710
Map to known/predicted exons 170,126,335 70,261,133 55,020,766 5,682,179
Map to known/predicted
exons (% of total)
82% 91% 61% 76%
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We also identified a further 252 genes that expressed at least two
distinct 39-terminal exons based on the distinct expression of two
39-UTR sequences (Table 2; Supplemental Table S3).
Once variant junctions were defined, they were mapped
against all well-defined full-length Ensembl transcripts to infer
isoform-specific transcript expression (Supplemental Methods). Of
the 5698 alternative variants, at least 11.2% (n = 639) resulted in a
predicted protein domain architecture that differed from that of
the canonical transcript (Supplemental Table S2A). Comparing non-
canonical junction expression in hES cells and paired-end RNA-seq
data for three human tissues revealed 2999 non-canonical junctions
expressed exclusively in hES cells (Fig. 1C; Supplemental Table S2A).
Of particular interest was the hES cell-specific splicing event de-
tected for DNA methyltransferase 3B (DNMT3B), which was pre-
dicted to encode a truncation of the C5 DNA methyltransferase
domain by 163 amino acids (Ensembl; Pfam) (Fig. 1A).
Alternative 59-exon usage in hES cells
Alternative 59-exon usage can be indicative of alternative promoter
usage, and thus alternative mechanisms of transcriptional regulation.
To identify discrete alternative 59 usage, collated hESC transcriptome
data were screened for regions sharing at least eight diagnostic exon–
exon junction tags with 59 exons of known alternative transcripts.
A total of 8749 alternative 59 exons were detected with high confi-
dence (Supplemental Table S4), and 910 of these were non-canonical
events. The genomic regions encoding these novel 59 exons were
then compared with hESC H3K4me3 ChIP-seq data (Ku et al. 2008),
with the majority, 96% (877/910), overlapping a well-defined
H3K4me3 region (i.e., SET) (Fig. 1B; Table 2; Supplemental Table S4).
An additional class of variant 59-UTR usage was also observed in
which the exonic signal continued to extend 59 of the canonical
transcription start site (Supplemental Table S5, 44 genes). Taken
together, these data provide a high-confidence set of transcripts
expressed in hESCs for which alternative promoter usage may occur.
Transcriptome discovery
In addition to summarizing transcription from known loci, a de-
tailed analysis was performed on expression arising outside known
exons. Ninety-two percent of all novel expression clusters (>1
RPKM) mapped within the introns (sense strand) or flanking re-
gions (within 10 kb) of well-defined genes (Fig. 2A). Examining this
expression more closely, we found evidence for 45 genes containing
intron retention events with high relative expression (Fig. 2C, OGT;
Supplemental Table S6) and 10 genes that contained a putative
extended internal exon (Fig. 2B, PHF10; Supplemental Table S6).
By far the most common novel expression event observed in
hESCs was 39-UTR extension of known genes (n = 1199) (Table 2;
Supplemental Table S7). The average size of the extended 39-UTR
expression was 2.1 kb, with a range of 500 bp to 14 kb. The ma-
jority of long 39 UTRs were found to possess a canonical poly-
adenylation signal at their 39 ends (733/1199). In almost all cases
(92.4%), hES H3K4me3 ChIP-seq analysis failed to provide any
epigenetic support for independent initiation of transcription
driving these events. Comparing to heart, liver, and brain, we
identified 452 long 39 UTRs that were unique to ES cells (Fig. 2E).
To resolve the nature of these transcripts, a sequence-based
‘‘virtual Northern’’ analysis was used in which hES poly(A)+ RNA
was separated into five size fractions (<500 bp, 0.5–2.0 kb, 2.0–3.5
kb, 3.5–6.5 kb, and >6.5 kb) and then subjected to sequencing.
When gene expression was quantified across each fraction, a ma-
jority of genes (71%) displayed peak gene expression in the size
fraction consistent with the canonical Ensembl annotation (Fig.
3A). In the case of genes predicted to express extended 39UTRs that
increased the transcript size by >2 kb, 71% (329/442) displayed
peak levels of expression in a larger size fraction concordant with
a 39-UTR extension (Fig. 3B,C). The ‘‘virtual Northern’’ approach
was subsequently used to validate other novel expression events
(20/24 intron retention, 11/13 extended 59 UTR) expected to sub-
stantially change the length of the expressed mRNA. In summary,
most novel expression events that we identified are likely to be
extensions of the surrounding gene, rather than independently
transcribed events.
Assessing subcellular enrichment and the preferential selection
of transcriptional complexity for translation
The extracellular surface plays a vital role in the response of ES cells
to external stimuli such as growth factors and differentiation cues.
Previously, we have used membrane-polysome translation state anal-
ysis (MPTSA) and microarrays to separate membrane and secreted
protein (known as M/S RNAs) encoding transcripts from all other
free and cytosolic polysome-associated RNAs (C/N RNAs) based on
their association with membrane-bound polysomes (Diehn et al.
2000; Diehn et al. 2006). To explore this subset of the transcriptome
more closely and to begin to determine the relationship between
transcriptional and translational complexity, we have performed
MPTSA coupled with deep sequencing.
Sequence-based analysis of M/S RNAs versus C/N RNAs
revealed a remarkable spatial separation of transcripts (Fig. 4A). At
the locus activity level, 2903 genes were found to express RNAs
significantly enriched in the M/S fraction, with a false discovery rate
of <0.01 based on known gene classifications (Table 2; Supplemental
Table S8; Stitziel et al. 2004; Kolle et al. 2009). Nine thousand one
hundred seventy-three genes were significantly under-represented
in the M/S fraction, suggesting cytoplasmic/nuclear localization
(Supplemental Table S9). The observed ratio of M/S:C/N signal
strongly correlated with previous published array-based studies on
the same fractions (Pearson correlation = 0.95) (Supplemental Fig.
S5; Kolle et al. 2009).
Given the wealth of non-canonical transcripts we had observed
to date, we next sought to determine what proportion of RNAs ob-
served in the mRNA fraction enter the translational machinery. To
Table 2. Analysis of cellular and membrane-polysome-enriched
(MPR-enriched) expression in human ESCs
Cellular RNA MPR enriched
Genes above 1 RPKM 14,081 2903




Genes with two or more splice variants 2701 224
59 ends detected 8749 1527
59 ends detected (variants) 910 114
Extended 59 UTRs 44 1
Alternative 39 exons (two or more) 260 21
Long 39 UTRs (non-canonical) 1199 153
Exon extension and intron
retention events
54 1
Expressed splice junctions are defined as eight tags that span the exon–
exon junction. For MPR enriched, the junction/exon must be at least
twofold enriched in the MPR fraction versus the CPR fraction and have an
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address this, we looked specifically at all transcriptional events arising
from the 2903 membrane-associated genes identified by MPTSA-Seq.
Within these genes we identified 689 non-canonical variants and 229
genes that expressed two or more variants enriched in the M/S RNA
fraction (Table 2; Supplemental Tables S10A,B, S11, S12). We sub-
sequently validated 24 of these events by real-time PCR (Supple-
mental Fig. S6).
We were also interested in determining whether novel fea-
tures such as extended 39 UTRs or retained introns would be sim-
ilarly enriched in the M/S fraction. To examine this, we looked at
the enrichment ratio (M/S RNA: C/N RNA) of each novel feature
and compared this with the canonical
gene-enrichment ratio for each of the
2905 membrane-associated genes. We
found strong evidence for membrane en-
richment of the majority of 39UTRs (Fig. 4
B,C), reinforcing their presence as a single
long transcript. This was also confirmed
for a panel of candidate genes by real-
time PCR (Supplemental Fig. S7). In con-
trast, several 59-UTR and intron retention
events in M/S genes were not enriched in
the M/S fraction (Fig. 4B).
Overlaying novel complexity
on the gene-network controlling
pluripotency
The impact of novel transcriptional com-
plexity on pluripotency was examined in
the context of the ‘‘Plurinet’’ gene net-
work, a gene-centric model consisting of
299 nodes under the control of the master
regulators of the stem cell state (transcrip-
tion factors POU5F1, SOX2, KLF4, and
NANOG). This model was originally cre-
ated using extensive gene-expression ar-
ray profiling of stem cells and progenitor
populations; ChIP-chip analysis of the
master regulators SOX2, POU5F1, and
NANOG; plus functional studies (Muller
et al. 2008). Overlaying hESC RNA-seq
data confirmed that 96% (287/299) of the
Plurinet loci were active in hES2 cells
(Supplemental Table S14, RPKM $ 1,
mRNA). In addition, we found 152 alter-
native splicing events for 98 genes, as well
as alternate 59-UTR expression (n = 23),
39-UTR extensions (n = 27), and one in-
stance of internal exon extension (Fig.
2B; Table 3, PHF10; Supplemental Table
S14). These results are summarized in
Table 3 and can be visualized within the
context of the Plurinet network in Supple-
mental Figure S8. Alternative splicing events
for 25 Plurinet genes were found to alter
the canonical domain architecture (Sup-
plemental Table S14), including DNMT3B
as discussed above.
A significant number of genes in the
Plurinet have been predicted to be regu-
lated by the pluripotency transcription
factors POU5F1, NANOG, and SOX2. These annotations are based
on overlaying canonical proximal promoters for each gene with
data from ChIP-chip experiments (Boyer et al. 2005). We looked to
redefine these models based on our RNA-seq data and recent ChIP-
seq data for POU5F1 and NANOG (Kunarso et al. 2010). We found
an additional 52 and 147 Plurinet genes that were targeted by
POU5F1 and NANOG, respectively, based on canonical gene usage
(Supplemental Fig. S8; Supplemental Table S14). Ten active alter-
nate 59 exons expressed by Plurinet genes show evidence for tar-
geting by POU5F1 and 24 by NANOG (based on alignment with
ChIP-seq data) (Supplemental Methods).
Figure 1. Alternative splicing in hES cells. (A) Integrated genome viewer (IGV) representation of the
DNMT3B locus showing strand-specific RNA-seq data (mRNA6; scale: 0–5000 tags); exon junctions
(black; detection threshold set at $8 tags); chromatin marks (H3K27, H3K36, and H3K4); two Ensembl
transcripts (dark blue); and the C5 DNA methyltransferase functional domain (Pfam; bottom black).
Detection of two non-canonical exon junctions (green shading) for DNMT3B indicated expression of at
least two different transcript isoforms (dark blue), with expression of variant junction 2 predicted to
result in truncation of the C5 DNA methyltransferase domain. (B) IGV view of the SET locus, including
ChIP-seq data for POU5F1 (light blue) and NANOG (pink) binding sites, showing alternate promoter
usage (red shading) and binding of both transcription factors at Promoter 1 and NANOG only at Promoter
2. (C ) Venn diagram indicating tissue-specific expression of non-canonical alternative splicing events.
Human ESC transcriptome and polysome RNA-seq
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Impact of transcriptional complexity on the hES cell surface
and signaling networks
Pluripotency is regulated by a balance of pathways and inter-
actions (Vallier and Pedersen 2005; Vallier et al. 2009). Growth
factors and other molecules present in the extracellular space bind
to receptors expressed on the hES cell surface, triggering a cascade
of reactions that, under appropriate conditions, favors hESC self-
renewal and thus the maintenance of pluripotency. When cul-
tured in suspension or as adherent single cells, hES cells rapidly
differentiate (Draper et al. 2004), thus cell–cell and cell–matrix
interactions also play important roles in the maintenance of
pluripotent hES cells. By regulating the key growth factor recep-
tors and mediating important cell–cell and cell–matrix interactions,
the cell-surface proteome of hESCs is critical in governing hESC
pluripotency and differentiation. We found evidence for the
Figure 2. Novel sequence usage in hESCs. (A) Distribution of novel transcribed clusters compared with Ensembl gene models. (B) IGV view of the PHF10
locus showing expression (scale: 0–250 tags) of an extended internal exon (red shading). (C ) IGV view of the OGT locus showing expression (scale: 0–500
tags) of a novel retained intron (blue shading) supported by junction tag evidence. (D) A consensus poly(A) sequence (blue) is highly enriched around the
39 end of predicted long 39 UTRs. Enrichment of a weaker poly(A) signal (red) is also shown, and a randomly chosen sequence (green) is not enriched. (E)
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expression, alternative splicing, and membrane-polysome associ-
ation of members of these pathways. Major signaling pathways
involved in hESC growth factor signaling, including members of
the TGFb/activin/nodal, WNT, and FGF signaling pathways (Fig. 5)
showed considerable variation both of ligands as well as cell-surface
receptors. In addition, sequence data for several genes involved with
cell-surface–extracellular-matrix interaction (Supplemental Fig. S9A)
and cell–cell contact (Supplemental Fig. S9B) pathways also showed
evidence for expression of non-canonical variant transcripts. Several
M/S gene variants (12%) expressed in the mRNA fraction were not
associated with membrane polysomes, indicating that variation at
the mRNA level did not always predict complexity at the trans-
lational level.
Discussion
We have used a strand-specific whole-
transcriptome shotgun sequencing ap-
proach to discern the entire cytoplasmic
transcriptome of human ES cells and the
complement of genes and variants that is
translated on membrane-bound polysomes.
These data provide the largest resource
to date of transcriptional output of the
pluripotent state of human ES cells.
hESCs express a diverse array
of transcript variants that have
an impact on the proteome
Consistent with previous studies, we have
identified a wide range of alternative splic-
ing events that increase the transcriptional
complexity expressed by mammalian cells
(Cloonan et al. 2008; Mortazavi et al. 2008;
Wang et al. 2008; Wilhelm et al. 2008). In
particular, we have identified several alter-
nate variant transcripts expressed by hu-
man ES cells within genes that are nec-
essary for maintenance of pluripotency.
For one of these, DNMT3B, at least two
alternate transcripts are expressed, one of
which is predicted to encode a protein
product with a truncated C5 DNA meth-
yltransferase domain relative to the ca-
nonical isoform based on Pfam domain
annotation of Ensembl transcripts. Trun-
cated DNMT3B isoforms are associated
with altered patterns of DNA methylation
in cancer cells (Ostler et al. 2007).
In some cases, we have found key
pluripotency-related genes that predomi-
nantly express a non-canonical junction.
An example of this is the Plurinet gene
BIRC5 (also known as survivin) for which
359 junction tags support expression of a
non-canonical junction, whereas expres-
sion of the canonical junction was sup-
ported by only 14 tags. In this case, the
non-canonical transcript isoform encodes
a functional survivin protein (Caldas et al.
2005), a 142-amino-acid component of the
chromosome passenger complex (CPC) and
a key regulator of chromosome segregation (Jeyaprakash et al. 2007).
The canonical transcript isoform corresponds to survivin2b, a 165-
amino-acid protein containing an alternate exon, 2b. Structural
evidence suggests that survivin2b is unlikely to be capable of forming
a functional CPC (Jeyaprakash et al. 2007). Thus, while RNA-seq
evidence suggests that survivin2b is expressed, its role in hES cells
is unclear.
Transcript complexity associated with translating ribosomes
Our study is the first to show at a full genome scale the number of
transcripts that can be actively associated with translating mem-
brane-bound ribosomes. We have used a method originally de-
Figure 3. Transcriptome-sequencing based ‘‘virtual Northern’’ validation of long 39-UTR expression.
(A,B) Peak expression for most transcripts was detected within the size fraction corresponding to the
canonical (Ensembl v55) transcript. (A) Graph of canonical transcript size against proportion of tran-
scripts in each fraction. The percentage of transcripts in each bin is shown for each of the five size
fractions (0–0.5 kb, 0.5–2 kb, 2–3.5 kb, 3.5–6.5 kb, and 6.5 kb+). (B) Distribution of peak gene ex-
pression relative to the expected (Ensembl canonical) size fraction. For example, if peak expression of
a 2.5-kb gene was detected in the 6.5-kb+ size fraction, it would be assigned a relative value of 3. (C )
Expression levels of individual genes across size fractions. Examples are shown of long 39-UTR-containing
genes (HELLS, GRPR, and POU2F1), a gene containing an extended internal exon (PHF10), and an intron-
retaining gene (OGT), genes for which peak expression was detected in the fraction consistent with
increased size. POU5F1 (no change expected) is shown for comparison.
Human ESC transcriptome and polysome RNA-seq
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veloped for use with microarrays (Diehn et al. 2000), which is based
on the separation of RNA associated with membrane-polysomes
from cytoplasmic polysomes and non-coding RNAs. Although
polysome association using this method can only be accurately
assessed for the M/S-encoding subset of the transcriptome, this
method has some advantages over other polysome isolation tech-
niques. First, separation between the membrane-polysome RNA
fraction and the cytosolic-polysome/free fraction is substantial,
with this method classifying more than two-thirds of expressed
genes (Fig. 4A). Second, a vast majority of RNA transcripts that are
enriched in the membrane-polysome fraction can be annotated by
the existence of signal peptides, transmembrane anchors, or an-
notations consistent with membrane localization (Supplemental
Table S8), allowing accurate thresholding for the discovery of novel
transcripts and transcript variants.
We found that a small percentage (12%) of expressed transcript
variants (measured by junction usage) within M/S genes were not
actively translated on membrane-bound polysomes. We also ob-
served (as in the case of AGPAT4) that most expressed introns are not
enriched within membrane-bound polysomes. It is likely that a
proportion of these transcript variants undergo nonsense-mediated
decay (NMD) and are degraded prior to translation (Chang et al.
2007). NMD can occur when a transcript expresses a premature stop
codon that is not in the last exon (Chang et al. 2007). These variants
may also be inhibited at the level of translation, for example, by
miRNAs. Together, these results also add to the disparity between
Figure 4. Enrichment of genes and alternative variants in the M/S enriched fraction. (A) Marked spatial separation of genes expressed in the membrane/
secreted (M/S) and cytoplasmic/nuclear (C/N) fractions. The histogram shows frequency of genes expressed (RPKM > 1) plotted against the log2 ratio of
M/S expression to C/N expression, log2(RPKMM/S/RPKMC/N). (B) Graph showing the correlation between canonical gene expression (x-axis) and ex-
pression of the novel annotated sequence (39 UTR, 59 UTR, intron retention; y-axis) for a subset of M/S genes. Notably, correlation with canonical gene
expression is high for 39 UTRs. (C ) UCSC Genome Browser view of four genes for which novel long 39 UTRs were detected by RNA-seq. Each track shows the
log2 ratio of M/S to C/N expression calculated at 50-bp windows across the gene for the positive strand. (Orange) M/S-enriched regions; (blue) regions not
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transcriptional activity and translational output, which can differ
by up to three orders of magnitude (Chang and Stanford 2008).
Despite the lower level of complexity associated with membrane-
bound polysomes, there were clear examples of loci encoding two
or more distinct transcripts predicted to output significantly dif-
ferent protein isoforms. Two pertinent examples are FLT1, en-
coding a receptor for the developmental regulator VEGF, and the
orphan receptor-encoding gene ROR1 (Dormeyer et al. 2008). Both
Table 3. Summary of alternative splicing in Plurinet genes including non-canonical (NC) splicing events, alternative 59UTRs, internal exon


























ANP32A ENSG00000140350 80.52 0 0 0 1 NCL ENSG00000115053 320.33 2 1 0 0
APEX1 ENSG00000100823 122.39 2 1 0 0 NOLC1 ENSG00000166197 48.74 1 0 0 0
APOE ENSG00000130203 575.67 2 0 0 0 NUDT1 ENSG00000106268 34.9 2 0 0 0
ARL4A ENSG00000122644 4.63 1 0 0 0 NUP153 ENSG00000124789 21.04 1 0 0 0
ARMC6 ENSG00000105676 22.25 1 1 0 0 NUP50 ENSG00000093000 17.37 2 0 0 0
ATIC ENSG00000138363 95.42 1 0 0 0 PA2G4 ENSG00000170515 72.01 1 0 0 1
AURKA ENSG00000087586 27.13 4 1 0 0 PAK1 ENSG00000149269 52.11 1 0 0 0
BAK1 ENSG00000030110 7.88 0 0 0 1 PASK ENSG00000115687 10.13 1 0 0 0
BCCIP ENSG00000107949 42.22 1 0 0 0 PBX1 ENSG00000185630 31.46 1 0 0 0
BIRC5 ENSG00000089685 33.11 3 0 0 0 PHB ENSG00000167085 34.69 1 0 0 0
BUB1B ENSG00000156970 51.44 1 0 0 0 PHF10 ENSG00000130024 15.99 0 0 1 0
C1orf103 ENSG00000121931 10.01 1 0 0 0 PIAS2 ENSG00000078043 17.26 1 0 0 1
CDC2 ENSG00000170312 88.73 2 1 0 0 PLSCR1 ENSG00000188313 12.91 1 0 0 0
CDC25C ENSG00000158402 10.92 2 0 0 0 PMAIP1 ENSG00000141682 52.01 1 0 0 0
CDC45L ENSG00000093009 15.23 2 0 0 0 POLD1 ENSG00000062822 20.99 2 0 0 0
CDC7 ENSG00000097046 25 1 0 0 0 POLD2 ENSG00000106628 78.1 0 0 0 0
CENPE ENSG00000138778 8.43 2 0 0 0 POLR1D ENSG00000186184 80.91 1 0 0 0
CHEK1 ENSG00000149554 27.56 2 1 0 1 POP1 ENSG00000104356 2.52 0 0 0 1
CHEK2 ENSG00000183765 27.13 4 0 0 0 POP5 ENSG00000167272 21.53 1 0 0 0
CKS1B ENSG00000173207 26.83 1 1 0 1 PPAP2C ENSG00000141934 8.94 1 0 0 0
COPS6 ENSG00000168090 55.29 1 0 0 0 PPM1B ENSG00000138032 24.86 1 0 0 1
CTBP2 ENSG00000175029 36.34 0 0 0 0 PRMT5 ENSG00000100462 32.11 1 1 0 0
CXADR ENSG00000154639 15.54 1 0 0 1 PRNP ENSG00000171867 5.14 1 1 0 0
DAZAP1 ENSG00000071626 102.04 1 0 0 0 PSIP1 ENSG00000164985 120.77 2 0 0 0
DNMT3B ENSG00000088305 333.93 2 0 0 0 PSMD11 ENSG00000108671 45.27 0 0 0 1
EWSR1 ENSG00000182944 104.14 5 0 0 0 PSME3 ENSG00000131467 47.1 1 0 0 0
EXO1 ENSG00000174371 8.41 1 0 0 0 PTPN6 ENSG00000111679 11.87 1 0 0 0
EXOSC3 ENSG00000107371 26.55 1 0 0 0 RAD51 ENSG00000051180 8.66 3 0 0 0
EXOSC9 ENSG00000123737 23.2 1 0 0 0 RBM14 ENSG00000173933 24.18 1 0 0 0
FLJ14668 ENSG00000035141 58.43 0 0 0 1 RBPMS ENSG00000157110 78.05 2 0 0 0
FUBP1 ENSG00000162613 74.22 2 0 0 1 RFC2 ENSG00000049541 26.43 1 0 0 0
FUS ENSG00000089280 260.29 1 0 0 0 RFC4 ENSG00000163918 52.86 1 0 0 0
GADD45A ENSG00000116717 10.78 0 0 0 0 RFC5 ENSG00000111445 17.75 1 0 0 0
GEMIN6 ENSG00000152147 17.74 2 0 0 0 RMND5B ENSG00000145916 23.4 0 0 0 1
GEMIN7 ENSG00000142252 16.24 1 1 0 0 SALL4 ENSG00000101115 49.03 1 0 0 1
GMNN ENSG00000112312 52.25 1 1 0 0 SEPHS1 ENSG00000086475 47.19 0 0 0 1
GPRIN2 ENSG00000204175 7.26 0 0 0 1 SET ENSG00000119335 332.65 1 1 0 0
GRB7 ENSG00000141738 12.16 3 1 0 0 SFRS1 ENSG00000136450 69.45 1 0 0 0
HMGA1 ENSG00000137309 636.08 4 1 0 0 SFRS3 ENSG00000112081 109.36 1 0 0 0
HMMR ENSG00000072571 32.38 1 0 0 0 SIP1 ENSG00000092208 13.6 3 0 0 0
HSP90AB1 ENSG00000096384 1000.71 1 0 0 0 SIRT1 ENSG00000096717 27.01 1 0 0 0
HSPA14 ENSG00000187522 12.85 2 0 0 0 SLC19A1 ENSG00000173638 9.6 0 0 0 1
HSPH1 ENSG00000120694 24.14 2 0 0 0 SMARCAD1 ENSG00000163104 18.32 2 0 0 0
ITGB3BP ENSG00000142856 25.25 2 0 0 0 SNRPB ENSG00000125835 148.71 0 0 0 0
KPNB1 ENSG00000108424 85.26 0 0 0 1 SNRPN ENSG00000128739 251.74 5 0 0 0
LCK ENSG00000182866 6.22 1 0 0 0 SNURF ENSG00000214265 307.26 0 2 0 0
LSM5 ENSG00000106355 19.35 1 1 0 0 SSB ENSG00000138385 123.01 1 1 0 0
MBD2 ENSG00000134046 2.67 1 0 0 0 STXBP2 ENSG00000076944 20.27 1 0 0 0
MCM10 ENSG00000065328 8.71 1 0 0 0 SUPT3H ENSG00000196284 13.74 1 0 0 0
MCM3 ENSG00000112118 117.21 1 0 0 0 SYNCRIP ENSG00000135316 31.77 1 1 0 0
MCM4 ENSG00000104738 81.99 0 0 0 1 TARBP2 ENSG00000139546 19.4 1 0 0 0
MCM5 ENSG00000100297 55.99 0 0 0 1 TCERG1 ENSG00000113649 44.08 1 0 0 0
MPP6 ENSG00000105926 11.05 2 1 0 1 TCOF1 ENSG00000070814 15.05 5 0 0 0
MRE11A ENSG00000020922 8.4 1 0 0 0 TGIF1 ENSG00000177426 67 3 2 0 0
MSH2 ENSG00000095002 50.3 2 0 0 0 TMPO ENSG00000120802 34.16 1 0 0 1
MSH3 ENSG00000113318 5.48 0 0 0 1 TPX2 ENSG00000088325 36.54 1 0 0 0
MSH6 ENSG00000116062 48.75 0 0 0 0 U2AF1 ENSG00000160201 128.42 2 0 0 0
MUTYH ENSG00000132781 19.07 1 1 0 0 WRN ENSG00000165392 5.53 0 0 0 1
MYB ENSG00000118513 5.18 1 0 0 0 ZNF281 ENSG00000162702 25.2 1 0 0 1
MYST2 ENSG00000136504 31.98 1 0 0 1 Total splicing events 152 23 1 27
NANOG ENSG00000111704 12.25 0 0 0 1 Total Plurinet genes affected 98 11 1 27
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of these genes encode tyrosine kinase receptors (Forrest et al. 2006).
In each case, there is sequence-based evidence for expression of a
longer membrane-spanning receptor isoform and a shorter secreted
isoform. Previous studies have shown that the secreted isoform of
FLT1 can act as a decoy receptor inhibiting the response of the
membrane-bound receptor to activation from the ligand VEGF
(Kendall and Thomas 1993). The action of VEGF is important for
directing hES cell differentiation to endothelial lineages (Nourse
et al. 2010), but VEGF is not necessary for maintenance of hES cell
pluripotency. Expression of secreted decoy receptors may be a way
for hES cells to inhibit the function of certain receptors under con-
ditions favoring pluripotency, while ensuring that the cells can rap-
idly respond in the presence of differentiation signals, such as in-
creased concentrations of growth factors like VEGF, which is used
in some directed differentiation protocols.
Abundance of long 39 UTRs
One of the striking aspects of our study was the high frequency of
long 59 and 39UTRs and retained introns detected by sequencing of
the complete transcriptome of hESC. In particular, 39 UTRs up to
14 kb were easily identified in our study, and long 39UTRS of >500
bp accounted for at least 9% of transcripts expressed by hESCs.
Many transcripts with long 39 UTRs would have remained un-
known to date because their size makes them difficult to clone,
and, as a result, such transcripts are likely under-represented in
current gene models such as Ensembl. Indeed, using a recent ver-
sion of Ensembl (Ensembl v62, June 2011), we find upwards of 600
UTRs that are longer by 500 bases or more than the longest cor-
responding annotated UTR (Supplemental Table S7). Previous
work has suggested that ES cells preferentially express shorter 39
UTRs ( Ji et al. 2009) compared with differentiated cells. While
we do not object to that idea, our study does suggest that there are
very long 39-UTR-containing transcripts expressed in hESCs (Fig.
3C), and we have found evidence that these transcripts can be
translated.
Several recent studies have predicted the presence of long 39
UTRs based on overlapping ESTs, RNA-seq, and/or predictive
methods (Mortazavi et al. 2008; Thorrez et al. 2010). However, in
most cases, the majority of these transcripts have not been inde-
pendently validated. We have shown here, using size fractionation/
transcriptome sequencing, that a majority of those transcripts with
an extended 39 UTR predicted by analysis of sequencing data are
true extensions of the canonical transcript rather than indepen-
dently transcribed RNAs. Interestingly, several of these 39 UTRs
overlap clusters of ESTs and predicted full-length non-coding
RNAs. It is likely that some of these predicted non-coding tran-
scripts are cloning artifacts that underestimate the full-length tran-
script. However, as highlighted in several recent reports, these may
be 39-UTR-associated transcripts (TASRs) produced by cleavage
(Fejes-Toth et al. 2009; Kolle et al. 2009; Mercer et al. 2010). Al-
though we do not object to this idea, we have shown that a number
of these long 39-UTR-containing transcripts are the primary tran-
scripts associated with translating polysomes, because there is no
decay in either the signal or the polysome association ratio along
the length of the long 39 UTR.
Defining independent transcripts by cellular fractionation
and sequencing
RNA sequencing technology has provided the means with which
to examine the hESC transcriptome at unprecedented resolution.
Using short-read high-throughput sequencing, combined with
two independent methods of subfractionating RNA populations,
we have produced a detailed characterization of the hESC tran-
scriptome. Based on mRNA sequencing, we uncovered a vast array
of alternative and novel expression events in hESCs, including
alternative splicing of exons, alternate UTR usage, intronic ex-
pression, and UTR extension events. We have demonstrated the
power of combining size fractionation and cellular subfractionation
with RNA-sequencing by using these methods to resolve cellular
transcriptional complexity within hESCs. Through systematic in-
Figure 5. Transcriptional complexity for growth factor interaction model for pathways active on the hES cell surface. The model is based on KEGG
pathway and IPA (Ingenuity Pathway Analysis, Ingenuity Systems) curated protein–protein interactions. Only genes enriched in the M/S fraction are
shown because these are most likely to be actively translated. Nodes are colored according to M/S expression levels (RPKM). Node shape is dependent on
molecular function according to IPA designation. Node outline color denotes the presence of at least two M/S-enriched alternatively spliced variants (red)
or the presence of novel sequence feature(s) (green) for the gene in the M/S fraction. Interactions between genes (edges) are displayed for ligand–
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tegration of our RNA-seq data with other data sets, we have rede-
fined existing hESC regulatory networks such as the Plurinet and
cell-surface interaction models. In doing so, we have produced com-
pelling evidence that the alternative and novel expression events
we have identified impact significantly on the regulation of the
pluripotent state. We envisage that this work will provide a compre-
hensive resource to guide further research into the transcriptomic
and epigenomic regulation of pluripotency.
Methods
Culturing of hESCs
HES2 hESCs were cultured as previously described (Laslett et al.
2007; Kolle et al. 2009) on mouse embryonic fibroblast (MEF)
feeder cells with media containing 20% knockout serum replacer
(KOSR)/Dulbecco’s modified Eagle’s medium (DMEM) F12, 1%
L-glutamine, 1% nonessential amino acids, 90 mM 2B-b-mercaptoeth-
anol (GIBCO Invitrogen; http://www.invitrogen.com), and fibro-
blast growth factor 2 (FGF-2, 10 ng/mL; Millipore; http://www.
millipore.com).
Isolation of RNA populations
Approximately 1 3 108 HES-2 hESCs were resuspended in 500 mL
of cold isotonic lysis buffer (10 mmol/L KCl, 1.5 mmol/L MgCl2,
and 10 mmol/L Tris-Cl at pH 7.4) and lysed by multiple passage
through a 21-gauge needle. Nuclei and cellular debris were re-
moved by centrifugation at 2000g for 2.5 min at 4°C. Cytoplasmic
poly-adenylated mRNA was extracted using the Oligotex Direct
mRNA kit (QIAGEN). Ribosomal RNA was depleted from poly-
adenylated mRNA fractions using the RiboClear kit (Ambion).
Membrane-polysome fractionation
Membrane-associated polysomes were fractionated from cytosolic
and other RNAs by sucrose density gradient centrifugation as de-
scribed previously (Kolle et al. 2009).
Size fractionation
Fifteen micrograms of mRNA (isolated as above) was size-frac-
tionated as follows: mRNA was incubated for 5 min at 55°C in a 25-
mL premix solution containing 5% formaldehyde, 40% formam-
ide, and 13 MOPS buffer. Formamide loading buffer (5 mL of 80%
formamide, 10 mM EDTA, 1 mg/mL xylene cyanol, and 1 mg/mL
bromophenol blue) was added to the RNA/premix, and the sample
was immediately loaded onto a 1.2% agarose gel containing 0.6%
formaldehyde in 13 MOPS buffer. The gel was run at 75 mA for 1.5
h, and gel slices were taken corresponding to the following sizes:
0–0.5 kb; 0.5–2 kb; 2–3.5 kb; 3.5–6.5 kb, and 6.5–20+ kb. Gel pieces
were dissolved in RLT buffer (QIAGEN) for 30 min at 37°C, purified
using the RNeasy Mini Kit (QIAGEN) according to the total RNA
preparation protocol, and eluted in a final volume of 100 mL. One
one-hundredth of the RNA from each fraction was run on the
Agilent Bioanalyzer (Agilent) to confirm the correct size distribu-
tion (Supplemental Fig. S2) and approximate yield.
Production of complex cDNA libraries
for transcriptome sequencing
Libraries were generated following the Whole Transcriptome Anal-
ysis Kit (Ambion) protocol with some modifications. One hundred
to 150 ng of RNA from whole-transcriptome and polysome-
fractionated samples and 15 ng of size-fractionated mRNA were
first fragmented into 50–100-–bp fragments by digestion with
RNase III (Ambion) for 10 min at 37°C followed by heat in-
activation for 20 min at 65°C. Fragmented RNA was purified on
a Microcon YM30 column (Microcon) and concentrated to a final
volume of 8 mL. Adapter sequences incorporating a single-stranded
random hexamer overhang to allow directional capture of RNA
molecules were hybridized to the RNA fragments and then in-
cubated with RNA ligase overnight at 16°C. The ligation products
were reverse-transcribed and used as templates for library PCR
amplification. Libraries were amplified for 15 cycles (mRNA and
polysome fractionated) or 25 cycles (size fractionated). Tran-
scriptome library products were fractionated on 3% TAE/agarose
gels (Bio-Rad), and gel slices corresponding to 125–150-nt and
150–175-nt fragments were excised and purified using the QIAquick
Gel Extraction Kit (QIAGEN) according to the manufacturer’s
guidelines, except that the gel slices were dissolved by mixing at
room temperature rather than at 55°C.
Solid sequencing
Library molecules were clonally amplified onto 1-mm magnetic
beads according to the SOLiD Template Bead Preparation protocol
and sequenced using a SOLiD Analyzer as per the manufacturer’s
instructions (Applied Biosystems).
Mapping SOLiD sequence data to the human genome
and exon–exon junctions
All SOLiD data were mapped to human genome (build hg19
[GRCh37]) and exon–exon junctions (generated from human
Ensembl v55 gene model) using the whole-transcriptome pipeline
in BioScope 1.2.1 (Life Technologies).
Quantitative real-time PCR
cDNA was produced from 20–100 ng of RNA using SuperScript III
(Invitrogen). Real-time PCR was performed using Sybr Green
(Applied Biosystems) on an ABI 7900HT (Applied Biosystems) us-
ing the following conditions: 2 min at 50°C, 10 min at 95°C, and
40 cycles of 15 sec at 95°C, 1 min at 60°C. For isoform-specific real-
time PCR, at least one primer was designed across the isoform-
specific splice junction. Real-time PCR primers are detailed in
Supplemental Table S15.
Determination of Ensembl canonical transcript length and long
39-UTR size validation
Sequence reads from size-fractionated libraries were mapped to the
human genome release hg19 (GHRC37) as above. The expression of
each transcript in each fraction was denoted in reads per kilobase per
million mappable tags. Values were offset by addition of 0.1 RPKM
and normalized by quantile using the Bioconductor function
‘‘quantile’’ in R. A transcript was designated into a size fraction based
on the peak normalized value. If a transcript had a predicted long 39
UTR, it was considered validated if the peak expression was in a size
range that corresponded with the increase in the length of the
transcript (for transcripts with long 39 UTRs of >2 kb).
Membrane-associated enrichment analysis
We used a Bayes Theorem–based classification as described pre-
viously (Stitziel et al. 2004) to determine a threshold ratio r (MPR/
CPR), where the probability of membrane-associated and secreted
genes in a test set above r is >99% (Stitziel et al. 2004). To determine
the test set, all Ensembl transcripts were functionally annotated
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Genome Research 2023
www.genome.org
 Cold Spring Harbor Laboratory Press on November 30, 2020 - Published by genome.cshlp.orgDownloaded from 
using subcellular localization information from manually curated
literature mining (Ingenuity IPA; http://www.ingenuity.com), and
in silico consensus prediction of signal peptides (SP) and/or trans-
membrane domains (TM) as described previously (Kolle et al.
2009). From these, a high-confidence classification set of mem-
brane-associated/secreted (M/S) and cytoplasmic/nuclear (C/N) genes
was generated. The expression data were floored at 0.1 RPKM, and
r was calculated for each gene in the test set where the expression
level in either the MPR or CPR is above 2 RPKM.
Bioinformatics analysis of sequencing data
All bioinformatics analysis of sequencing data, including gene ex-
pression counts, alternative splicing prediction, and prediction of
long 59 and 39UTRs, was performed using customized scripts in Perl
or R. Details of individual analysis pipelines are supplied in the
Supplemental Methods.
Comparison with existing data sets
ES data were compared to published microarray and RNA-seq sam-
ples, and details of individual comparisons are supplied in the
Supplemental Methods.
Data access
Raw and processed data (.wig) have been submitted to the NCBI
Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/
geo/) under accession nos. GSE25842 and GSE24355; and tdf (cov-
erage), BAM (read alignment), and Ensembl RPKM files are avail-
able at http://grimmond.imb.uq.edu.au/hES_transcriptome.
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